CollPlant Biotechnologies (CLGN) Shares Outstanding (Diluted Average) (2019 - 2025)

CollPlant Biotechnologies has reported Shares Outstanding (Diluted Average) for 7 years, with the latest figure at $12.2 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 6.54% year-over-year to $12.2 million; the trailing twelve-month figure through Dec 2025 stood at $12.2 million (up 6.54% YoY), and the FY2025 full-year result was $12.2 million, up 6.54% from the prior year.
• Shares Outstanding (Diluted Average) for Q4 2025 stood at $12.2 million, up from $11.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $12.2 million in Q4 2025, with the low at $11.0 million in Q4 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $11.6 million across 5 years, with a median of $11.5 million in 2024.
• Annual changes were most pronounced in 2021 — Shares Outstanding (Diluted Average) soared 73.76% — and 2022, when it decreased 7.8%.
• CollPlant Biotechnologies' Shares Outstanding (Diluted Average) stood at $12.0 million in 2021, then dropped by 7.8% to $11.0 million in 2022, then climbed by 3.23% to $11.4 million in 2023, then rose by 0.57% to $11.5 million in 2024, then grew by 6.54% to $12.2 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $12.2 million (Q4 2025), $11.5 million (Q4 2024), and $11.4 million (Q4 2023), per Business Quant data.